Effects of polymer type, polymer: Direct tabletting agent ratio and tabletting method on verapamil hydrochloride extended release from hydroxypropylmethylcellulose matrix tablets

Bu çalışma farklı hidroksipropilmetilselüloz (HPMC) tiplerinin ve HPMCdoğrudan tabletleme ajanı (dta) oranının, tek tabakalı ve üç tabakalı matris tabletlerden Verapamil Hidroklorür^ün (VRP HCl) salımı üzerindeki etkilerine odaklanmıştır. İncelenen polimerler Methocel K100LV, K15M, K100M ve dta Ludipress® LCE'dir. Sekiz adet tek tabakalı ve dört adet üç tabakalı matris tablet doğrudan basım yöntemi kullanılarak hazırlanmıştır. Etkin madde salım çalışmaları USP XXVH'de yer alan uzatılmış salım yapan ilaç şekillerine ait makaleler prosedürüne uygun olarak yapılmıştır. HPMC tipi ve oranının etkin madde salımı üzerine etkili olduğu saptanmıştır. HPMC miktarı ve viskozluğundaki artışın, matrislerden etkin madde şahmının yavaşlamasına neden olduğu tespit edilmiştir. İç ve dış tabakalarda düşük viskozluğa sahip HPMC içeren tabletler, farmakope limitlerine yakın veya limitler içinde salım profilleri vermişlerdir. USP XXVII kriterlerine uyan üç tabakalı matris tablet (Fi 2) ve referans ürüne (Isoptin®-KKH) ait salım verileri matematiksel modeller (sıfır derece, birinci derece, Higuchi, Hixson-Crowell, Korsmeyer-Peppas), fark faktörü (f,) ve benzerlik faktörü (fz) kullanılarak değerlendirilmiştir. VRP HCVin salım kinetikleri F12 için en iyi Higuchi modeline, Isoptin®-KKH için sıfır derece kinetik modeline uyum göstermiştir. Fİ 2 ve Isoptin®-KKH*ın her ikisi de n katsayılarına göre Anomali durumu göstermiştir, f (5.2) ve f2 ( 71.4) değerlerine göre Fİ2 ile Isoptin®-KKH benzer kabul edilmiştir.

Polimer tipinin, polimer: Doğrudan tabletleme ajanı oranının ve tabletleme yönteminin hidroksipropilmetilselüloz yapılı matris tabletlerden verapamil hidroklorür'ün uzatılmış salımı üzerine etkileri

This work has focused on the effects of different hydroxypropylmethylcellulose (HPMC) types and HPMC.direct tabletting agent (DC-agent) ratio on Verapamil Hydrochloride (VRP HCl) release from monolayered and three-layered matrix tablets. Investigated polymers were Methocel K100LV, K15M, K100M and DC-agent was Ludipress® LCE. Eight formulations were prepared as monolayered matrix tablets while four formulations were prepared as three-layered matrix tablets by direct compression method. Drug release studies were carried out according to the method given for Delayed Release Articles in USP XXVII. HPMC types and ratios were found to be effective on drug release. Increasing amount and viscosity grade of HPMC resulted in a decrease in release of drug from the matrices. Tablets containing low viscosity grade HPMC at inner and outer layers presented release profiles close to or within the limits of pharmacopeia. Release data of three-layered matrix tablet (F12) and the reference product (Isoptin -KKH) which were in agreement with USP XXVII criteria, were evaluated by mathematical models (zero order, first order, Higuchi, Hixson-Crowell, Korsmeyer-Peppas), difference factor (fi) and similarity factor (fi).. The kinetics of VRP HCl release from FI2 showed best fit to Higuchi model and Isoptinm-KKH well fitted to zero order kinetic model. FI2 and Isoptin -KKH were both show Anomalous transport mechanism 'according tn thcir n exponent values. Depending on the results off] (5.2) and J2 (71.4) values, F12 and lsuplinK-KKIl were found to be similar with regard to release kinetics.

___

  • 1. Martindale-The Extra Pharmacopeia, 32nd edition. The Pharmaceutical Press., London, 352-372(1999).
  • 2. McTavish, D., Sorkin, E.M. "Verapamil: An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension", Drugs. 38(1), 19-76 (1989).
  • 3. Vasquez, M.J., Perez-Marcos, B., Gomez-Amoza, J.L., Martinez-Pacheco, R., Souto, C., Concheiro, A. "Influence of technological variables on release of drugs from hydrophilic matrices", Drug Dev. Ind. Pharm. 18, 1355-1375 (1995).
  • 4. Vueba, M.L., Batista de Carvalho, L.A.E., Veiga, F., Sousa, J.J., Pina, M.E. "Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets", Eur. J. Pharm. Biophartn., (in press) (2004).
  • 5. Web site of Technical Information, Dow Chemical Company, "Using methocel cellulose ethers for controlled release of drugs in hydrophilic matrix systems", U.S.A., (2000).
  • 6. Costa, P., Manuel, J., Lobo, S. "Modelling and comparison of dissolution profiles", Eur. J. Pharm. Sci. 13(2), 123-133 (2001).
  • 7. Narasimhan, B., Langer, R. "Zero-order release of micro and macromolecules from polymeric devices: the role of the burst effect", J. Control. Release 47, 13-20 (1997).
  • 8. Conte, U., Maggi, L. "A flexible technology for the linear, pulsatile and delayed release of drugs, allowing for easy accommodation of difficult in vitro targets", J. Control. Release 64, 263-268 (2000).
  • 9. Nelson, K.G., Smith, S.J., Bennett, R.M. "Constant-release diffusion systems: rate control by means of geometric configuration" in Controiled-Released Technolog: Pharmaceutical Applications, Vol. 348. Acs Symposium Series, American Chemical Society, Washington, DC, p: 324-340 (1987).
  • 10. Peppas, N.A., Sahlin, J.J. "A simple equation for the description of solute release: III. Coupling of diffusion and relaxation", Int. J. Pharm. 57, 169,172 (1989).
  • 11. Lee, P.I. "Kinetics of drug release from the hydrogel matrices", J. Control. Release 2, 277-288 (1985).
  • 12. Abdul, S., Poddar, S.S. "A flexible technology for modified release of drugs: multi layered tablets ",J. Control Release 97, 393-405 (2004).
  • 13. Conte, U., Maggi, L., La Manna, A. "Compressed barrier layers for constant drug release from swellable matrix tablets ", Stp Pharma Sci. 4,107-113 (1994).
  • 14. Colombo, P., Conte, U., Gazzaniga, A., Maggi, L., Sangalii, M.E., Peppas, N.A., La Manna, A. "Drug release modulation by physical restriction of matrix swelling", Int. J. Pharm.63,43-48 (1990).
  • 15. Conte, U., Maggi, L., Colombo, P., La Manna, A. "Multi-layered hydrophilic matrices as consant release devices (Geomatrix™ Systems)", J. Control. Release 26, 39-47 (1993).
  • 16. Conte, U., Maggi, L.," Multilayered tablets as drug delivery devices", Pharm. Technol. 22(3), 174-182(1998).
  • 17. Yang, L., Venkatesh, G., Fassihi, R. "Compaction simulator study of a novel triple-layer tablet matrix for industrial tabletting ", Int. J. Pharm. 152,45-52 (1997).
  • 18. Rathbone, M.J., Hadgraft, J., Roberts, M.J. "Smartrix System" in Modified Release Drug Delivery Technology, Vol. 126. Marcel Dekker Inc., New York, 59-76 (2003).
  • 19. Banakar, U.V. "Pharmaceutical Dissolution Testing" in Drugs and Pharmaceutical Sciences, Vol. 49. Marcel Dekker Inc., New York, p : 162 (1992).
  • 20. Moore, J.W., Flanner, H.H. "Mathematical comparison of curves with an emphasis on in vitro dissolution profiles", Pharm. Tech. 20(6), 64-74 (1996).
  • 21. Alğın, E., Baykara, T. "Preparation of sustained release hydrophilic matrix tablets by using different cellulose derivatives", Master of Science Thesis, (2002).
  • 22. Ford, J.L., Rubinstein, M.H., Hogan, J.E. "Formulation of sustained-release promethazine hydrochloride tablets using hydroxypropylmethylcelhilose matrices", Int. J. Pharm. 24, 327-338 (1985).
  • 23. Feeiy, L.C., Davis, S.S. "Influence of surfactans on drug release from hydroxypropyl methlycellulose matrices", Int. J. Pharm. 41, 83-89 (1988).
  • 24. Jordan, M.P., Taylor, J., Hindmarch, P. "Characterisation of hydroxyproyl methylcellulose hydrophilic matrices using multivariate analysis techniques", Technical Data of Colorcon Limited, Dartfort, Kent England (2000).
  • 25. Conte, U., Maggi, L. "Modulation of dissolution profiles from Geomatrix® multilayer tablets containing drugs of different solubility", Biomat. 17, 889-896 (1996).
  • 26. Maggi, L., Bruni, R., Conte, U. "High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms", Int. J. Pharm. 195, 229-238 (2000).
  • 27. Ford, J.L., Mitchell, K., Rowe, P., Armstrong, D.J., Elliott, P.N.C., Rostron, C., Hogan, J.E. "Mathematical modeling of drug release from hydroxypropylmethyl cellulose matrices: effect of temperature", Int. J. Pharm. 71,95-104 (1991).
  • 28. Ritger, P.L., Peppas, N.A. "A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs", J. Control. Release 5,23-26 (1987).
  • 29. Siepmann, J., Peppas, N.A. "Modeling of drug release from delivery systems based on hydroxypropylmethylcellulose (HPMC)", Adv. Drug Del. Rev. 48, 139-157 (2001).
  • 30. Colombo, P., Bettini, R., Catellani, P.L., Santi, P., Peppas, N.A. "Drug volume fraction profile in the gel phase and drug release kinetics in hydroxypropylmetyl cellulose matrices containing a soluble drug", Eur. J. Pharm. Sci. 9, 33-40 (1999).